US › Healthcare

Medpace Holdings Inc (MEDP)

US · Healthcare · Diagnostics & Research

$575.08+0.31%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$707.3M
Revenue YoY
+17.2%
Net profit
$121.4M
Profit YoY
+34.5%
EPS
$4.25
EPS estimate
$4.08
Net margin
17.2%

EPS came in at 4.25 against a street estimate of 4.08 — a beat of 4.2%.

Key statistics

Market cap
$16.11B
P/E
33.9
Forward P/E
33.6
P/B
37.09
Book value
$15.54
EPS (TTM)
$17.01
52-week high
$677.90
52-week low
$373.00
50-day MA
$504.31
200-day MA
$518.04
Beta
1.15

Analyst view

Analysts rate Medpace Holdings Inc a hold (2 buy, 10 hold, 0 sell out of 12) with an average price target of $581.83.

Shareholding

Insiders
19.88%
Institutions
89.28%

Largest institutional holders

FundStake
BlackRock Inc8.85%
Vanguard Group Inc8.10%
AQR Capital Management LLC4.85%
Vanguard Portfolio Management, LLC4.02%
Vanguard Capital Management, LLC3.62%
Geode Capital Management, LLC2.67%
State Street Corp2.44%
Wasatch Advisors LP2.28%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Medpace Holdings Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.